On March 10, Natalia Genere, MD had their review titled “Possible Association between Lenvatinib Use and Primary Adrenal Insufficiency: Additional Studies Very Much Needed,” published in “Clinical Thyroidology.” The review takes a look at a study showing how adverse events partnered with lenvatinib may lead to primary adrenal insufficiency. “Lenvatinib is a multitarget tyrosine kinase inhibitor approved for […]